Business Wire · Sep 2025
Announced a strategic agreement with Siemens Healthineers and a Series A extension totaling up to $25 million to advance the CRISPR-based product platform.
CRISPR powered Diagnostics with results in minutes.
Company research
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Overview
VedaBio is a San Diego-based biotechnology company building the amplification-free CRISPR Cascade™ platform for ultra-rapid, highly multiplexed molecular detection, aimed at decentralized diagnostics and other clinical/industrial applications.
Primary product
CRISPR Cascade™ molecular detection platform
Founded
2021
Headquarters
11125 Flintkote Ave. Suite A, San Diego, CA 92121, USA
Team size
11-50
Industry
Biotechnology Research
Sub-industry
Molecular diagnostics / CRISPR diagnostics
Offices
11125 Flintkote Ave. Suite A, San Diego, CA 92121, USA
Open Positions
0 jobs at VedaBio
No open positions
Check back later for new openings